Psilocybin use patterns and perception of risk among a cohort of Black individuals with Opioid Use Disorder
Journal of Psychedelic Studies August 5, 2022 John Clifton, Annabelle M. Belcher, Aaron D. Greenblatt et al. 6 citations
Among Black individuals diagnosed with Opioid Use Disorder recruited from an urban methadone program, most had heard of psilocybin mushrooms but only 17.8% had ever used them. Over 80% perceived a risk or were unsure of the risk for most psilocybin-related items. About half were willing to try therapy incorporating psilocybin, and half said they would be more likely to try it if FDA-approved for OUD. Most preferred to stay on methadone alone; only one participant chose psilocybin treatment without methadone. The authors suggest culturally informed treatment models and outreach to increase minority representation in psilocybin research.